Evidence map›Paper›PMID 37414809›Full record

ArticleScientific reports2023

Biomarker integration for improved biodosimetry of mixed neutron + photon exposures.

Igor Shuryak, Shanaz A Ghandhi, Evagelia C Laiakis, Guy Garty, Xuefeng Wu, Brian Ponnaiya, Emma Kosowski, Evan Pannkuk, Salan P Kaur, Andrew D Harken and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Igor ShuryakCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA. is144@cumc.columbia.edu.
Shanaz A GhandhiCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Evagelia C LaiakisDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Guy GartyCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Xuefeng WuCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Brian PonnaiyaCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Emma KosowskiDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Evan PannkukDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Salan P KaurCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Andrew D HarkenCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Naresh DeoliCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Albert J FornaceDepartment of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
David J BrennerCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.
Sally A AmundsonCenter for Radiological Research, Columbia University Irving Medical Center, 630 West 168Th Street, VC-11-234/5, New York, NY, 10032, USA.

Funding

Sample Engineering CoreU19AI067773 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI AMUNDSON, SALLY A. · 2005 to 2024
$105.4M
NIAID NIH HHS U19 AI067773
6 · The paper itself

Abstract

There is a persistent risk of a large-scale malicious or accidental exposure to ionizing radiation that may affect a large number of people. Exposure will consist of both a photon and neutron component, which will vary in magnitude between individuals and is likely to have profound impacts on radiation-induced diseases. To mitigate these potential disasters, there exists a need for novel biodosimetry approaches that can estimate the radiation dose absorbed by each person based on biofluid samples, and predict delayed effects. Integration of several radiation-responsive biomarker types (transcripts, metabolites, blood cell counts) by machine learning (ML) can improve biodosimetry. Here we integrated data from mice exposed to various neutron + photon mixtures, total 3 Gy dose, using multiple ML algorithms to select the strongest biomarker combinations and reconstruct radiation exposure magnitude and composition. We obtained promising results, such as receiver operating characteristic curve area of 0.904 (95% CI: 0.821, 0.969) for classifying samples exposed to ≥ 10% neutrons vs. < 10% neutrons, and R

Indexed as

Radiation ExposureRadiation InjuriesAnimalsMiceNeutronsPhotonsRelative Biological Effectiveness

Identifiers

PMID37414809
PMCPMC10325958

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.